|
ERYP
|
Erytech Pharma S.A.
|
US
|
NASDAQ
|
|
ETNB
|
89bio, Inc.
|
US
|
NASDAQ
|
|
FBIOP
|
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
|
US
|
NASDAQ
|
|
FREQ
|
Frequency Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
GNFT
|
GENFIT S.A.
|
US
|
NASDAQ
|
|
GRTX
|
Galera Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HOOK
|
HOOKIPA Pharma Inc.
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
US
|
NASDAQ
|
|
IGMS
|
IGM Biosciences, Inc.
|
US
|
NASDAQ
|
|
IMUX
|
Immunic, Inc.
|
US
|
NASDAQ
|
|
IPHA
|
Innate Pharma S.A.
|
US
|
NASDAQ
|
|
ISEE
|
IVERIC bio, Inc.
|
US
|
NASDAQ
|
|
KRTX
|
Karuna Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LCTX
|
Lineage Cell Therapeutics, Inc.
|
US
|
AMEX
|
|
LMNL
|
Liminal BioSciences Inc.
|
US
|
NASDAQ
|
|
MIRM
|
Mirum Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MNPR
|
Monopar Therapeutics Inc.
|
US
|
NASDAQ
|
|
MORF
|
Morphic Holding, Inc.
|
US
|
NASDAQ
|
|
MREO
|
Mereo BioPharma Group plc
|
US
|
NASDAQ
|